Clinical Trial Results: Liver Cancer

Product Name: Avastin [bevacizumab]
Date of Report: To be Published
Phase: II
Modified-dose capecitabine (Xeloda) plus bevacizumab (Avastin) for the treatment of advanced or metastatic hepatocellular carcinoma (HCC): a phase II, single-arm study

Product Name: Avastin [bevacizumab]
Date of Report: To be Published
Phase: II
A Study of Avastin (Bevacizumab) and TACE Treatment in Patients With Liver Cancer.

Product Name: Avastin [bevacizumab]
Date of Report: To be Published
Phase: II
A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Product Name: Xeloda [capecitabine]
Date of Report: To be Published
Phase: II
A Study of Xeloda (Capecitabine) and PEGASYS® in Treatment-Naïve Patients With Advanced Liver Cancer